Evidence map›Paper›PMID 19183153›Full record

ArticleAlimentary pharmacology & therapeutics2009

Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States.

S Garud, D Leffler, M Dennis, J Edwards-George, D Saryan, S Sheth, D Schuppan, S Jamma, C P Kelly

Open access · bronzeAbstract read
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Celiac disease poses significant risk in developing depression, anxiety, headache, epilepsy, panic disorder, dysthymia: A meta-analysis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Coeliac disease: complications and comorbidities.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Celiac Disease in the Elderly.Current treatment options in gastroenterology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Extraintestinal manifestations of coeliac disease.Nature reviews. Gastroenterology & hepatology · 2015
    Review
  18. Hepatobiliary Quiz (Answers)-15 (2015).Journal of clinical and experimental hepatology · 2015
    Article
  19. Article
  20. Psychological morbidity of celiac disease: A review of the literature.United European gastroenterology journal · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

S GarudThe Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. sgarud@bidmc.harvard.edu
D Leffler
M Dennis
J Edwards-George
D Saryan
S Sheth
D Schuppan
S Jamma
C P Kelly
Beth Israel Deaconess Medical Center · USHarvard University · USHasbro (United States) · US

Funding

RESEARCH TRAINING IN GASTROENTEROLOGYT32DK007760 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KELLY, CIARAN P · 1999 to 2019
$4.6M
Non-invasive markers of celiac disease activity during gluten challengeK23DK082619 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LEFFLER, DANIEL ALEXANDER · 2009 to 2013
$887k
NIDDK NIH HHS K23 DK082619NIDDK NIH HHS T32 DK007760NIDDK NIH HHS T32 DK07760
6 · The paper itself

Abstract

backgroundPrevious studies yielded conflicting results regarding the presence of an association between coeliac disease (CD) and psychiatric disorders including depression. This association has not been studied in the United States.

aimTo determine the prevalence of psychiatric and autoimmune disorders in patients with CD in the US compared with control groups.

methodsIn a case control study, the prevalence of psychiatric and autoimmune disorders was compared in 600 CD patients, 200 irritable bowel syndrome (IBS) patients and 200 healthy controls.

resultsThe prevalence of depression in CD was 17.2% and was similar to that in IBS (18.5%, P = 0.74) and controls (16.0%, P = 0.79). Among CD patients, type I diabetes mellitus (DM) was identified as a significant risk factor for depression (P < 0.01) with 37% of patients with both CD and type I DM having clinical depression.

conclusionThe prevalence of depression in CD is similar to that in other chronic gastrointestinal diseases and healthy controls. However, there is a markedly elevated risk of depression in patients with both type I DM and CD. Differing rates of type 1 DM among coeliac populations may account for disparity in published rates of depression in patients with CD.

Indexed as

AdultAutoimmune DiseasesCase-Control StudiesCeliac DiseaseDepressive DisorderDiabetes Mellitus, Type 1FemaleHumansMaleMiddle AgedPrevalenceRisk FactorsUnited States

Identifiers

PMID19183153
PMCPMC2763921
OpenAlexW2108639407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.